Involvement of naïve T cells in the pathogenesis of osimertinib-induced pneumonitis
Abstract Osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, effectively treats EGFR-mutated non-small cell lung cancer. Drug-induced interstitial lung disease, a potentially fatal complication of osimertinib, involves an increase in lymphocytes in the...
Сохранить в:
| Главные авторы: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Portfolio
2025-03-01
|
| Серии: | Scientific Reports |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1038/s41598-025-95271-9 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|